WuXi PharmaTech Co., Ltd. Announces Fourth-Quarter and Full-Year 2012 Results, Share Repurchase Program
3/8/2013 6:26:30 AM
SHANGHAI, March 7, 2013 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial results for the fourth quarter and full year of 2012.
comments powered by